{{Rsnum
|rsid=6852678
|Gene=CDKL2
|Chromosome=4
|position=75617565
|Orientation=plus
|GMAF=0.1928
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CDKL2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 52.2 | 39.8 | 8.0
| HCB | 89.8 | 9.5 | 0.7
| JPT | 87.6 | 12.4 | 0.0
| YRI | 66.0 | 29.9 | 4.1
| ASW | 64.9 | 29.8 | 5.3
| CHB | 89.8 | 9.5 | 0.7
| CHD | 95.4 | 4.6 | 0.0
| GIH | 80.0 | 20.0 | 0.0
| LWK | 71.8 | 25.5 | 2.7
| MEX | 70.7 | 27.6 | 1.7
| MKK | 55.1 | 39.7 | 5.1
| TSI | 49.0 | 42.2 | 8.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21124932
|Title=Exploring the link between germline and somatic genetic alterations in breast carcinogenesis
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}